Scientists at NINDS are conducting an inpatient study using an experimental medication called 1-octanol for the treatment of essential tremor. Eligible participants should be age 21 or older, have a diagnosis of essential tremor of the arms which improves with mild to moderate alcohol use, not pregnant, able to fast for a period of 12 hours, and on no tremor medications.
The study requires 2 visits: a 1-day screening visit and a 4-day hospitalization. The study will take place at the NIH Clinical Center in Bethesda, MD. All travel and study-related expenses will be paid by NIH. There is no cost for participation or for any tests associated with the research.
For more information, contact Dr. Fatta Nahab, Human Motor Control Section, Medical Neurology Branch, NINDS; telephone: 301-402-3496. Please refer to study 05-N-0092.